The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 07, 2017
Filed:
Jun. 25, 2015
Applicant:
Genzyme Corporation, Cambridge, MA (US);
Inventors:
Hitesh R. Bhagat, Wayland, MA (US);
Jeffrey M. Goldberg, Framingham, MA (US);
Assignee:
GENZYME CORPORATION, Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 31/787 (2006.01); A61K 9/00 (2006.01); A61K 31/00 (2006.01); A61K 31/785 (2006.01); A61K 9/16 (2006.01); A61K 8/81 (2006.01); A61K 8/898 (2006.01); A61K 47/34 (2006.01); A61K 47/36 (2006.01);
U.S. Cl.
CPC ...
A61K 31/787 (2013.01); A61K 9/0053 (2013.01); A61K 9/0056 (2013.01); A61K 9/0095 (2013.01); A61K 9/1652 (2013.01); A61K 31/00 (2013.01); A61K 31/785 (2013.01); A61K 8/8105 (2013.01); A61K 8/817 (2013.01); A61K 8/898 (2013.01); A61K 47/34 (2013.01); A61K 47/36 (2013.01);
Abstract
A powder formulation comprises a pharmaceutically acceptable anionic stabilizer and an aliphatic amine polymer or a pharmaceutically acceptable salt thereof mixed with the anionic stabilizer. The powder formulation is conveniently packaged in a container, such as a sachet. A method of treating a subject with hyperphosphotemia with the powder formulation is also disclosed.